Post Profile






CONFIRMED: The maker of EpiPen overcharged the government and lawmakers are furious

The Centers for Medicare & Medicaid Services (CMS) confirmed to lawmakers that Mylan, the drug company that makes EpiPen, has been overcharging the government for the life-saving allergy medication. And naturally, lawmakers are furious about it. Here's a statement from Senator Ron Wyden (D-OR): “Today’s letter is more evidence that while Mylan irresponsibly raised the price of EpiPen, they were also bilking taxpayers out of millions of dollars,” Wyden and Pallone said.
read more

share

Related Posts


The maker of the EpiPen is tanking after it was called out for hiking the drug's price by over 500%

Business & Finance : Business Insider: Money Game

Mylan Pharmaceuticals, the company that makes the emergency allergy medication EpiPen, is under pressure. The drugmaker's stock is down 4% Tuesday. That's after Sens. Chuck Grassley of Iowa and Richard Blumenthal of Connecticut wrot...

The CEO of the company that makes EpiPens said healthcare is facing a bubble just like the 2007 housing crisis, but it's not (myl)

Business & Finance : Business Insider: Money Game

Mylan, the maker of emergency allergy medication EpiPen, has taken it on the chin over the past few days after an outcry over the drug's price. CEO Heather Bresch took to the airwaves on Thursday to defend the company, telling CNBC ...

EXCLUSIVE: Preferred Pharmacy Networks Are Back in 85% of the 2017 Medicare Part D Plans

Medical / Pharmaceutical : Drug Channels

The Centers for Medicare & Medicaid Services (CMS) just released the initial data on the 2017 Medicare Part D plans. Our exclusive analysis reveals that preferred cost sharing pharmacy networks are back. For 2017, 85% of Medicare Pa...

U.S. lawmakers question Mylan's Medicaid EpiPen rebates

Health : Reuters: Health

(Reuters) - Two key U.S. congressional committee members on Friday called for an investigation into whether Mylan NV, under fire for raising the price of its EpiPen device, overcharged the government's low-income healthcare program ...

Lawmakers are accusing Mylan of overcharging Medicaid for the EpiPen — and the stock is tanking (MYL)

Business & Finance : Business Insider: Money Game

Mylan could be facing another issue when it comes to the EpiPen, a drug used to treat severe allergic reactions that has seen a price increase of more than 500% since 2007. The company's stock was down by more than 4% Friday shortly...

Comments


Copyright © 2016 Regator, LLC